Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

FAQs

Want to know how to be involved with WAERP? Or how long the project is running for? View our Frequently Asked Questions (FAQs) for answers to these questions and more.

Research Team

The Australian Epithelial Research Program (WAERP) comprises of several parties, including our Chief Investigators, Compliance, Scientific and Clinical Teams, and our Student group.

News & Events

Research to help identify which children will develop asthma and to design more specific asthma treatments supported by Federal Government funding

Research focussed on identifying which children will develop asthma, and developing more specific asthma treatments, has been supported by the National Health and Medical Research Council’s (NHMRC) Ideas Grants announced by the Federal Government on 14 December 2022.

News & Events

300th participant recruited to crucial respiratory research program

A research program, which enables over 25 important respiratory research studies to be undertaken, celebrated the recruitment of its 300th participant on 14 December 2022.

Sialic acid-to-urea ratio as a measure of airway surface hydration.

Sialic acid-to-urea ratio as a measure of airway surface hydration. Although airway mucus dehydration is key to pathophysiology of cystic fibrosis (CF

Multiple Breath Washout Cannot Be Used for Tidal Breath Parameter Analysis in Infants

Multiple Breath Washout Cannot Be Used for Tidal Breath Parameter Analysis in Infants Background: Multiple breath washout (MBW) testing with SF6 gas

News & Events

New study to find COVID-fighting properties in existing medications thanks to national grant

Nearly 50 existing prescription medications already used by Australians will be tested by new research in the fight against COVID’s mutant variants.

Lung inflammation and simulated airway resistance in infants with cystic fibrosis

Lung inflammation and simulated airway resistance in infants with cystic fibrosis Cystic fibrosis (CF) is characterized by small airway disease; but

Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis

Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis The solute carrier family 6 member 14 (

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis. Authors: Miquéias